Eflornithine for treating high-risk neuroblastoma with complete or partial response after immunotherapy [ID4060] Technology appraisal guidance TBC Elamipretide for treating Barth syndrome in people of ...
Cemiplimab for adjuvant treatment of high-risk cutaneous squamous cell carcinoma after surgery and radiotherapy [ID6659] Technology appraisal guidance 24 March 2027 Cemiplimab for treating recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results